These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37068593)

  • 1. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
    Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
    J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.
    Li C; Voos KM; Pathak M; Hall G; McCrae KR; Dreveny I; Li R; Emsley J
    J Thromb Haemost; 2019 May; 17(5):759-770. PubMed ID: 30801944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
    Renné T; Gailani D; Meijers JC; Müller-Esterl W
    J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
    Mohammed BM; Sun MF; Cheng Q; Litvak M; McCrae KR; Emsley J; McCarty OJT; Gailani D
    J Thromb Haemost; 2024 Jan; 22(1):225-237. PubMed ID: 37813198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
    Hooley E; McEwan PA; Emsley J
    J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
    You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
    Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikrein.
    Colman RW; Lin Y; Yan WY; McCrae KR; Shenoy SS; Harris RB
    Immunopharmacology; 1997 Jun; 36(2-3):193-200. PubMed ID: 9228546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.
    Seaman FS; Baglia FA; Gurr JA; Jameson BA; Walsh PN
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):715-21. PubMed ID: 7818472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.
    Ivanov I; Shakhawat R; Sun MF; Dickeson SK; Puy C; McCarty OJ; Gruber A; Matafonov A; Gailani D
    Thromb Haemost; 2017 Apr; 117(4):671-681. PubMed ID: 28124063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.
    Bar Barroeta A; Marquart JA; Bakhtiari K; Meijer AB; Urbanus RT; Meijers JCM
    J Thromb Haemost; 2022 Nov; 20(11):2538-2549. PubMed ID: 35815349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XI.
    Baglia FA; Badellino KO; Ho DH; Dasari VR; Walsh PN
    J Biol Chem; 2000 Oct; 275(41):31954-62. PubMed ID: 10924522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
    Mahdi F; Shariat-Madar Z; Schmaier AH
    J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.
    Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W
    Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
    You JL; Scarsdale JN; Harris RB
    J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain.
    Wong SS; Østergaard S; Hall G; Li C; Williams PM; Stennicke H; Emsley J
    Blood; 2016 Jun; 127(23):2915-23. PubMed ID: 27006387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A binding site for thrombin in the apple 1 domain of factor XI.
    Baglia FA; Walsh PN
    J Biol Chem; 1996 Feb; 271(7):3652-8. PubMed ID: 8631976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct evidence for multifacial contacts between high molecular weight kininogen and plasma prekallikrein.
    Lin Y; Shenoy SS; Harris RB; Colman RW
    Biochemistry; 1996 Oct; 35(39):12945-9. PubMed ID: 8841140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.